Literature DB >> 26358108

A New Pathway for Sympathetic Cardioprotection in Heart Failure.

Paul C Simpson1.   

Abstract

Entities:  

Keywords:  Editorials; epigenenomics; heart failure; methyl-CpG-binding protein 2; microRNAs; receptor, adrenergic

Mesh：

Substances：

Year:  2015        PMID： 26358108      PMCID： PMC4692358          DOI： 10.1161/CIRCRESAHA.115.307246

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  34 in total

1.  Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection.

Authors:  Takahisa Noma; Anthony Lemaire; Sathyamangla V Naga Prasad; Liza Barki-Harrington; Douglas G Tilley; Juhsien Chen; Philippe Le Corvoisier; Jonathan D Violin; Huijun Wei; Robert J Lefkowitz; Howard A Rockman
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

2.  Elevated expression of MeCP2 in cardiac and skeletal tissues is detrimental for normal development.

Authors:  Matías Alvarez-Saavedra; Loreto Carrasco; Sylvia Sura-Trueba; Vera Demarchi Aiello; Katherina Walz; José Xavier Neto; Juan I Young
Journal:  Hum Mol Genet       Date:  2010-03-04       Impact factor: 6.150

3.  Posttranscriptional regulation of the β2-subunit of cardiac L-type Ca2+ channels by MicroRNAs during long-term exposure to isoproterenol in rats.

Authors:  Elba D Carrillo; Yesenia Escobar; German González; Ascención Hernández; José M Galindo; María C García; Jorge A Sánchez
Journal:  J Cardiovasc Pharmacol       Date:  2011-11       Impact factor: 3.105

4.  Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132.

Authors:  Rajesh Katare; Federica Riu; Kathryn Mitchell; Miriam Gubernator; Paola Campagnolo; Yuxin Cui; Orazio Fortunato; Elisa Avolio; Daniela Cesselli; Antonio Paolo Beltrami; Gianni Angelini; Costanza Emanueli; Paolo Madeddu
Journal:  Circ Res       Date:  2011-08-25       Impact factor: 17.367

Review 5.  Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure.

Authors:  Brian C Jensen; Timothy D O'Connell; Paul C Simpson
Journal:  J Mol Cell Cardiol       Date:  2010-11-28       Impact factor: 5.000

Review 6.  Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery.

Authors:  Anthony Yiu-Ho Woo; Ying Song; Rui-Ping Xiao; Weizhong Zhu
Journal:  Br J Pharmacol       Date:  2014-12-17       Impact factor: 8.739

Review 7.  β₂ AR agonists in treatment of chronic heart failure: long path to translation.

Authors:  Mark I Talan; Ismayil Ahmet; Riu-Ping Xiao; Edward G Lakatta
Journal:  J Mol Cell Cardiol       Date:  2010-10-01       Impact factor: 5.000

8.  Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction.

Authors:  Cinzia Perrino; Sathyamangla V Naga Prasad; Lan Mao; Takahisa Noma; Zhen Yan; Hyung-Suk Kim; Oliver Smithies; Howard A Rockman
Journal:  J Clin Invest       Date:  2006-06       Impact factor: 14.808

9.  An alpha1A-adrenergic-extracellular signal-regulated kinase survival signaling pathway in cardiac myocytes.

Authors:  Yuan Huang; Casey D Wright; Chastity L Merkwan; Nichole L Baye; Qiangrong Liang; Paul C Simpson; Timothy D O'Connell
Journal:  Circulation       Date:  2007-02-05       Impact factor: 29.690

10.  MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis.

Authors:  Jelena Mann; David C K Chu; Aidan Maxwell; Fiona Oakley; Nian-Ling Zhu; Hidekazu Tsukamoto; Derek A Mann
Journal:  Gastroenterology       Date:  2009-10-17       Impact factor: 22.682
View more
  3 in total

1.  Adrenergic Receptors in Individual Ventricular Myocytes: The Beta-1 and Alpha-1B Are in All Cells, the Alpha-1A Is in a Subpopulation, and the Beta-2 and Beta-3 Are Mostly Absent.

Authors:  Bat-Erdene Myagmar; James M Flynn; Patrick M Cowley; Philip M Swigart; Megan D Montgomery; Kevin Thai; Divya Nair; Rumita Gupta; David X Deng; Chihiro Hosoda; Simon Melov; Anthony J Baker; Paul C Simpson
Journal:  Circ Res       Date:  2017-02-20       Impact factor: 17.367

2.  Re-evaluation of combination therapy in chronic obstructive pulmonary disease (COPD).

Authors:  Carlos A Vaz Fragoso; Thomas M Gill; Linda S Leo-Summers; Peter H Van Ness
Journal:  Respir Med       Date:  2019-03-29       Impact factor: 3.415

Review 3.  New Treatment Strategies for Alcohol-Induced Heart Damage.

Authors:  Joaquim Fernández-Solà; Ana Planavila Porta
Journal:  Int J Mol Sci       Date:  2016-09-29       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.